21/04/2010 17:30:00

L'Oréal USA signs agreement to acquire Essie Cosmetics

Related content
13 Oct - 
L'OREAL : Disclosure of total number of voting rights a..
21 Sep - 
L'ORÉAL: News Release: "The passing of Mrs Liliane Bett..
11 Sep - 
L'OREAL : Disclosure of total number of voting rights a..

Clichy, April 21st, 2010 at 6:30 p.m.

L'Oréal USA signs agreement

to acquire Essie Cosmetics

L'Oréal USA today announced the signature of an agreement to acquire Essie Cosmetics, the ultimate nail color authority in the US, founded in 1981 by Essie Weingarten, and mainly sold in American salons and spas.

Essie's net sales through the last 12-month period were $28 million.

This acquisition will enable L'Oréal to increase its share in the nail color and care market which has seen significant growth year over year.

The acquisition is expected to be completed within 60 to 90 days, subject to customary US and international regulatory approvals.

"This news release does not constitute an offer to sell, or a solicitation of an offer to buy L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our Internet site www.loreal-finance.com.

This news release may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements."

Contacts at L'ORÉAL (Switchboard: +33 1 47 56 70 00)

Individual shareholders and market authorities

Mr Jean Régis CAROF

Tel: +33 1 47 56 83 02

jcarof@dgaf.loreal.com

Financial analysts and Institutional investors

Mrs Caroline MILLOT

Tel: +33 1 47 56 86 82

cmillot@dgaf.loreal.com

Journalists

Mrs Stephanie CARSON-PARKER

Tel: +33 1 47 56 76 71

scarsonparker@dgc.loreal.com

For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, and the Internet site for shareholders and investors, http://www.loreal-finance.com, or its mobile version on your cell phone, http://loreal-finance.mobi; alternatively, call +33 1 40 14 80 50.

Copyright Hugin

The appendixes relating to the press release are available on:

http://www.hugingroup.com/documents_ir/PJ/CO/2010/165279_88_Y17F_Oreal-USA-21-04-2010-US.pdf

Information réglementée :

Type : Nouvelle information

Thème(s):

Communiqués au titre de l'obligation d'information permanente - Activité de l'émetteur (acquisitions, cessions...)

This announcement is originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

[CN#165279]

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Alliance Trust PLC : Net Asset Value(s)

23/10/2017 13:14:06
ALLIANCE TRUST PLC                                    At the close of business on Friday 20 October 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 778.5p -       including income, 787.1p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inco..

Rathbones : Form 8.3 - [Clinigen Group PLC]

23/10/2017 10:58:08
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Rathbone Brothers PLC (b) Owner or controller of ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
H.B. Fuller Poised for Global Growth with Acquisition of Royal Adhesives & Sealants
2
Sequent Announces Two New Sequent Platform Versions
3
Simmons Reports Third Quarter 2017 Earnings
4
Novartis combination adjuvant therapy Tafinlar® + Mekinist® receives FDA Breakthrough Therapy Designation for stage III BRAF V600 mutation-positive melanoma patients
5
MEDIA ADVISORY: US Commerce Secretary Wilbur Ross to Hold Listening Session at National Minority Supplier Development Council Annual Conference

Related stock quotes

L'OREAL 185.35 -0.1% Stock price decreasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 October 2017 18:09:57
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171023.1 - EUROWEB7 - 2017-10-23 19:09:57 - 2017-10-23 18:09:57 - 1000 - Website: OKAY